General Range

Nxfyllin-LM

Novalab Healthcare Pvt. Ltd.Panchkula, Haryana

Nxfyllin-LM Tablets by Novalab Healthcare Pvt. Ltd. contain Acebrophylline (Sustained Release), Levocetirizine Dihydrochloride and Montelukast, a combination of respiratory medicines intended for selected conditions involving allergic symptoms, airway inflammation and bronchial obstruction.

Acebrophylline is a xanthine-derived respiratory medicine with bronchodilator and mucus-regulating properties. It may help improve airflow and facilitate mucus clearance in selected patients with obstructive respiratory conditions. The sustained-release formulation is designed to release the medicine gradually over time.

Levocetirizine Dihydrochloride is a second-generation antihistamine that blocks histamine H1 receptors, helping relieve allergy-related symptoms such as sneezing, runny nose, itching and watery eyes.

Montelukast is a leukotriene receptor antagonist that works by blocking leukotrienes involved in allergic reactions and airway inflammation. It may be prescribed for selected patients with asthma or allergic rhinitis when medically appropriate.

Nxfyllin-LM Tablets may be considered for patients experiencing a combination of allergic respiratory symptoms and chronic airway obstruction when a healthcare professional determines that all three ingredients are necessary.

The medicine is intended for prescribed respiratory symptom management and is not suitable for immediate relief during acute asthma attacks.

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.